These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2832773)

  • 21. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basis for poliomyelitis surveillance in Kabul City.
    Serý V; Thraenhart O; Zácek K; Brogger S; Omar A; Saboor A
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):311-8. PubMed ID: 4318510
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results.
    Patti AM; Santi AL; Vulcano A; Casagni L; Lamberti A; De Stefano Caraffa D; Vellucci L; Fiore L; Fara GM
    Ann Ig; 2002; 14(4 Suppl 5):1-57. PubMed ID: 12389292
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observation on immunizing effect of live trivalent oral poliomyelitis vaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Sep; 16(5):285-9. PubMed ID: 7151589
    [No Abstract]   [Full Text] [Related]  

  • 27. Polio immunization.
    Tulchinsky TH; Goldblum N
    N Engl J Med; 2001 Jan; 344(1):61-2; author reply 62-3. PubMed ID: 11187114
    [No Abstract]   [Full Text] [Related]  

  • 28. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
    Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: Oral polio immunisation.
    Wolfsdorf J; Singer B; Cruickshank JG
    S Afr Med J; 1975 Mar; 49(10):344. PubMed ID: 163500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comment on the contribution by Pietsch, R., H. Riegel: Implementation of poliomyelitis revaccination].
    Dittmann S; Koch MA; Diedrich S; Maass G; Böthig B
    Gesundheitswesen; 1993 Jul; 55(7):381-3. PubMed ID: 8396469
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of vaccinating children against poliomyelitis according to the epidemic indices in the Dagestan ASSR in 1978].
    Boĭko VM; Karaseva IA; Martynenko IN; Balakireva RG; Kazantseva VA
    Vopr Virusol; 1980; (4):479-80. PubMed ID: 6252700
    [No Abstract]   [Full Text] [Related]  

  • 33. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of the results of serum studies of children and adults for antibodies to the poliomyelitis virus in a multiyear effort at vaccinal prevention of this infection].
    Boĭko VM; Karaseva IA; Balakireva RG; Lazikova GF; Pichushkov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):78-82. PubMed ID: 6282015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Course of immunity in subjects repeatedly vaccinated with Sabin virus].
    Crovari P; Bori D; De Flora S
    G Ig Med Prev; 1971; 12(1):19-32. PubMed ID: 4340479
    [No Abstract]   [Full Text] [Related]  

  • 36. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Revaccination of school children with a live vaccine against poliomyelitis].
    Koza J; Matyásová I; Skovránek V; Danes L; Losová M
    Cesk Pediatr; 1983 Apr; 38(4):207-11. PubMed ID: 6303606
    [No Abstract]   [Full Text] [Related]  

  • 39. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Poliomyelitis associated with a vaccine: 2 clinical cases].
    González E; Cordero J
    Rev Med Chil; 1988 May; 116(5):461-4. PubMed ID: 2854294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.